These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 22446901)

  • 1. Thyroid associated orbitopathy.
    Maheshwari R; Weis E
    Indian J Ophthalmol; 2012; 60(2):87-93. PubMed ID: 22446901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sight-threatening Graves' orbitopathy: Twenty years' experience of a multidisciplinary thyroid-eye outpatient clinic.
    Tramunt B; Imbert P; Grunenwald S; Boutault F; Caron P
    Clin Endocrinol (Oxf); 2019 Jan; 90(1):208-213. PubMed ID: 30339291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal management of Graves orbitopathy: a multidisciplinary approach.
    Soeters MR; van Zeijl CJ; Boelen A; Kloos R; Saeed P; Vriesendorp TM; Mourits MP
    Neth J Med; 2011; 69(7):302-8. PubMed ID: 21934174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnosis and treatment of dysthyroid orbitopathy: a multidisciplinary disease].
    Leray B; Imbert P; Thouvenin D; Boutault F; Caron P
    J Fr Ophtalmol; 2013 Dec; 36(10):874-85. PubMed ID: 24239215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asymmetric Graves' Orbitopathy.
    Panagiotou G; Perros P
    Front Endocrinol (Lausanne); 2020; 11():611845. PubMed ID: 33391188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation and management of Graves' orbitopathy.
    Lee HB; Rodgers IR; Woog JJ
    Otolaryngol Clin North Am; 2006 Oct; 39(5):923-42, vi. PubMed ID: 16982255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of patients with Graves' orbitopathy: initial assessment, management outside specialised centres and referral pathways.
    Perros P; Dayan CM; Dickinson AJ; Ezra D; Estcourt S; Foley P; Hickey J; Lazarus JH; MacEwen CJ; McLaren J; Rose GE; Uddin J; Vaidya B
    Clin Med (Lond); 2015 Apr; 15(2):173-8. PubMed ID: 25824071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Graves' ophthalmopathy].
    Eckstein A; Esser J
    Internist (Berl); 2010 May; 51(5):584, 586-8, 590-2, passim. PubMed ID: 20383481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Graves' orbitopathy].
    Balázs C
    Orv Hetil; 2006 Jun; 147(22):1011-7. PubMed ID: 16913090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroid eye disease: a review.
    Weiler DL
    Clin Exp Optom; 2017 Jan; 100(1):20-25. PubMed ID: 27701774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraocular pressure and superior ophthalmic vein blood flow velocity in Graves' orbitopathy: relation with the clinical features.
    Konuk O; Onaran Z; Ozhan Oktar S; Yucel C; Unal M
    Graefes Arch Clin Exp Ophthalmol; 2009 Nov; 247(11):1555-9. PubMed ID: 19609549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An update on thyroid-associated ophthalmopathy in children and adolescents.
    Szczapa-Jagustyn J; Gotz-Więckowska A; Kocięcki J
    J Pediatr Endocrinol Metab; 2016 Oct; 29(10):1115-1122. PubMed ID: 27682712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of difficult endocrine orbitopathy cases].
    Breuer T; Ammann-Rauch D; Tasman AJ
    Laryngorhinootologie; 2007 May; 86(5):376-81. PubMed ID: 17252323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Socioeconomic Disparities in the Presentation and Treatment of Graves' Disease and Thyroid Eye Disease.
    Vargason CW; Chelnis JG; Barahimi BI; Mawn LA
    Semin Ophthalmol; 2016; 31(4):409-14. PubMed ID: 27385363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Management of moderate and severe dysthyroid orbitopathy: about 22 cases].
    Daldoul N; Knani L; Gatfaoui F; Mahjoub H
    Pan Afr Med J; 2017; 27():257. PubMed ID: 29187926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Graves' ophthalmopathy from the internist's perspective].
    Laubner K; Weber WA; Seufert J
    Ophthalmologe; 2011 May; 108(5):410-6. PubMed ID: 21590351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Graves' orbitopathy: diagnosis, epidemiology and treatments].
    Lun AY; Le Bras M; Scharbarg E; Morcel P; Hadjadj S; Lebranchu P; Drui D
    Rev Med Interne; 2022 Apr; 43(4):242-251. PubMed ID: 35221112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Superior ophthalmic vein thrombosis: A rare complication of Graves' orbitopathy.
    Sorrentino D; Taubenslag KJ; Bodily LM; Duncan K; Stefko T; Yu JY
    Orbit; 2018 Jun; 37(3):175-178. PubMed ID: 29053044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current and Emerging Treatment Strategies for Graves' Orbitopathy.
    Genere N; Stan MN
    Drugs; 2019 Feb; 79(2):109-124. PubMed ID: 30659423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of moderate to severe orbitopathy: Current modalities and perspectives.
    Bouzehouane N; Borson-Chazot F; Abeillon J; Caron P
    Ann Endocrinol (Paris); 2021 Apr; 82(2):92-98. PubMed ID: 33676921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.